回盛生物(300871.SZ)发布前三季度业绩，归母净利润1.88亿元，增长494.28%

Core Viewpoint - The company reported significant growth in both revenue and net profit for the first three quarters of 2025, indicating strong operational performance and financial health [1] Financial Performance - The company's operating revenue for the first three quarters reached 1.26 billion yuan, representing a year-on-year increase of 58.92% [1] - The net profit attributable to shareholders of the listed company was 188 million yuan, showing a remarkable year-on-year growth of 494.28% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 166 million yuan, reflecting a substantial year-on-year increase of 611.92% [1] - The basic earnings per share stood at 1.0134 yuan [1]